Caring4Cancer

NEW YORK (Reuters Health) - The stress and anxiety associated with receiving results of a prostate-specific antigen (PSA) test for prostate cancer is not relieved by using rapid PSA tests, but men still prefer to have their results quickly, results of a study indicate.

NEW YORK (Reuters Health) - Prostate cancer deaths fell substantially in the decade after one Austrian state began free PSA screening tests for all men ages 45 to 75, according to a new study.

A report from the 2008 ASCO Genitourinary Cancers Symposium

Expression of the PTOV1 gene helps predict the likelihood of the development of prostate cancer among men with high-grade prostatic intraepithelial neoplasia (HG-PIN). These results were recently published in the journal Clinical Cancer Research.

A recent study conducted by the American Cancer Society reports that although few cancer survivors follow recommendations for lifestyle changes aimed to improve health and well-being, adhering to these guidelines may improve quality of life among prostate cancer survivors. Full details of the study were recently published in the Journal of Clinical Oncology.

NEW YORK (Reuters Health) - Early onset of the bone-thinning disease osteoporosis seems to be related to an increased risk of certain cancers, while later onset of osteoporosis may be related to a decreased risk of other cancers, researchers report.

NEW YORK (Reuters Health) - Cancer survivors are just as likely to be obese and sedentary as people who have never been diagnosed with the disease, a new study from Canada shows.

The immunotherapeutic vaccine GVAX® provides promising activity in patients with recurrent prostate cancer. These results were recently presented at the 2008 annual meeting of the American Association for Cancer Research.

LONDON (Reuters) - Extracts from a mushroom used for centuries in Eastern Asian medicine may stop breast cancer cells from growing and could become a new weapon in the fight against the killer disease, scientists said on Tuesday.

A large study conducted in Austria reveals that large weight gains or losses may influence an individual’s risk for developing certain types of cancer, including prostate cancer. Complete details of the study were published in the Annals of Oncology.

Intermittent administration of Taxotere® (docetaxel) appears to provide as much benefit, with fewer side effects, than continuous administration of Taxotere among patients with hormone-refractory prostate cancer. These results were recently presented at the 23^rd annual meeting of the European Association of Urology.

NEW YORK (Reuters Health) - The use of hormone treatment for prostate cancer has declined, offset only in part by increases in surgical testicle removal, since Medicare reduced reimbursement for administration of these drugs that block testosterone starting in 2004.

NEW YORK (Reuters Health) - Whether a man is recovering from cancer or helping his spouse to deal with cancer, how his wife is coping emotionally will play a key role in his physical health, a new American Cancer Society (ACS)-funded study shows.

LONDON (Reuters) - U.S. and European scientists have found six more genes that make people more susceptible to developing type 2 diabetes, in a study they say may help prevent and treat the chronic condition.

A recent study indicates that prostate cancer treatment may be associated with changes in quality of life that impact satisfaction with treatment outcomes for both patients and their spouses or partners. These findings were published in the New England Journal of Medicine.

NEW YORK (Reuters Health) - Men with diabetes are at increased risk for bothersome lower urinary tract symptoms and frequent nighttime urination or "nocturia," investigators have shown. This is particularly true for black men with diabetes.

NEW YORK (Reuters Health) - A potent chemo drug that is activated by prostate specific antigen, or PSA, shows high activity against prostate cancer implanted in mice, researchers report.

BOSTON (Reuters Life!) - Age, race and obesity affect how satisfied men are with their treatment for prostate cancer, U.S. researchers said on Wednesday.

Differences between the prescribed dose of radiation in intensity modulated radiation therapy (IMRT) and the dose that’s actually delivered in prostate cancer treatment may make comparison studies difficult to interpret. These findings were reported in the Journal of the National Cancer Institute.

NEW YORK (Reuters Health) - After treatment for thyroid cancer, patients may face a slightly increased risk of developing a second primary malignancy elsewhere in the body, research suggests.

Public health Web sites may not be as useful to men concerned about prostate cancer as educational online presentations about the disease. This recent study was published in the Archives of Internal Medicine.

NEW YORK (Reuters Health) - Testing men with prostate cancer for a substance called endoglin in their blood may help doctors know if the cancer has spread outside the gland to the lymph nodes, new research shows.

NEW YORK (Reuters Health) - Visiting Web sites that provide general patient information on prostate cancer is not the best way for men to get help deciding whether to be screened for the disease, a new study shows.

WASHINGTON (Reuters) - The U.S. death rate from cancer has continued a steady decline that began in the early 1990s but it will still kill a projected 565,650 Americans this year, the American Cancer Society said on Wednesday.

NEW YORK (Reuters Health) - Working in a job that requires a continuous level of high physical effort may decrease the likelihood of a man developing prostate cancer, researchers report.

LONDON (Reuters) - A single prostate cancer screening test before age 50 can help predict which men might develop aggressive forms of the disease, even 25 years before a diagnosis, researchers said on Friday.

NEW YORK (Reuters Health) - An experimental vaccine can provide long-term protection against prostate cancer in mice genetically predisposed to the disease, new research indicates.

WASHINGTON (Reuters) - Men in their 70s and older who are diagnosed with early stage prostate cancer can safely "watch and wait" because they are not likely to die of it, researchers confirmed on Wednesday.

NEW YORK (Reuters Health) - Wives and other caregivers of men with prostate cancer may be at risk of anxiety, fatigue and other symptoms that exact a toll on the quality of their lives, a study suggests.

LONDON (Reuters) - Three studies published on Sunday identify at least ten new genes that raise a man's risk of prostate cancer, information that could lead to better screening and targeted drugs to treat the disease.

NEW YORK (Reuters Health) - A combination of biomarkers detectable in urine more accurately detects prostate cancer than the standard PSA blood test and the newer PCA3 test, according to a report in the journal Cancer Research.

NEW YORK (Reuters Health) - Overall, people who suffer from psoriatic arthritis do not appear to have a higher risk of cancer compared to the general population, according to a new study.

NEW YORK (Reuters Health) - Taking antioxidant supplements won't reduce cancer risk, according to a new analysis of a dozen studies including more than 100,000 patients. In fact, the researchers found, smokers who take beta carotene supplements could be increasing their risk of smoking-related cancer and death.

NEW YORK (Reuters Health) - Surgery that avoids disturbing the nerves during the removal of the prostate gland -- a "nerve-sparing" approach to radical prostatectomy -- shortens the period until continence is regained and improves the long-term continence rates for most patients, new research shows.

According to an article recently published in the Journal of the National Cancer Institute, testosterone levels do not appear to be associated with risk of developing prostate cancer.

NEW YORK (Reuters Health) - Taking antioxidant supplements won't reduce cancer risk, according to a new analysis of a dozen studies including more than 100,000 patients. In fact, the researchers found, smokers who take beta carotene supplements could be increasing their risk of smoking-related cancer and death.

LONDON (Reuters) - Natural levels of a man's testosterone do not affect his prostate cancer risk as some had thought, a finding that should spur scientists to rethink their approach to the disease, researchers said on Tuesday.

A recent study published in the New England Journal of Medicine reveals that genetic variants located in five different chromosomal regions have been associated with prostate cancer.

According to an article recently published in the Journal of the American Medical Association, androgen suppression therapy (AST), also referred to as androgen deprivation therapy, in addition to radiation therapy improved survival in some men with early prostate cancer. This improvement was limited to men with high-risk prostate cancer and those without other significant medical conditions.

NEW YORK (Reuters Health) - New research suggests a link between acne and prostate cancer, but the study's authors urge caution in interpreting their findings.

NEW YORK (Reuters Health) - Gene changes in five chromosome regions appear to have a combined effect for increasing the risk of prostate cancer, according to a report in The New England Journal of Medicine.

WASHINGTON (Reuters) - Distrust of doctors and concern over being abused as human guinea pigs may explain why U.S. blacks have been less willing than whites to volunteer to take part in medical studies, researchers said on Monday.

Compared with radiation therapy alone, a short course of androgen deprivation therapy before radiation therapy improves several outcomes among men with locally advanced prostate cancer. These results were published in the Journal of Clinical Oncology.

NEW YORK (Reuters Health) - In a large study of U.S. veterans, the use of a commonly prescribed class cholesterol-lowering drugs called "statins," which include drugs such as Lipitor, reduced the cancer rate by about 25 percent.

LONDON (Reuters) - A little more sunshine might help you live longer, according to new study findings suggesting that for some people health benefits from the sun outweigh the risk of skin cancer.

NEW YORK (Reuters Health) - Men without children have a lower risk of prostate cancer compared with fathers, but those who father a brood of kids appear to have a relatively low risk also, the results of a large study suggest.

WASHINGTON (Reuters) - U.S. blacks continue to get inferior cancer treatment compared with whites, researchers reported Monday in a study showing that disparities first documented in the early 1990s persist despite efforts to erase them.

LOS ANGELES (Reuters Life!) - Singer and songwriter Stephen Stills, best known as one third of rock trio Crosby, Stills and Nash, has undergone successful surgery for prostate cancer and is recovering well, his wife said.

NEW YORK (Reuters Health) - New research suggests that two months of "androgen deprivation" therapy, which reduces levels of the androgen, a male hormone, can help slow the growth of locally advanced prostate cancer when given before and during radiotherapy. Plus, the short course of androgen deprivation therapy does not increase the risk of death from cardiovascular disease, which had been a concern.

NEW YORK (Reuters Health) - The amount of calcium and vitamin D in the diet appears to have little or no impact on the risk of prostate cancer, but the consumption of low-fat or nonfat milk may increase the risk of the malignancy, according to the results of two studies published in the American Journal of Epidemiology.